Results 1 - 10 for Cis-platin

CPY Document Subject
170 IARC MONOGRAPHS SUPPLEMENT 7 elSPLATIN (Group lA) A. Evidence for carcinogenicity to humans (inadequate) No epidemiological study of cisplatin as a single agent was available ...
http://monographs.iarc.fr/ENG/Monographs/suppl7/Suppl7-53.pdf
open  pop

CIS platin
C IS platin Injection * WARNINGS Cisplatin*should*be*administered*under*the*supervision* of*a*qualified*physician*experienced*in*the*use*of*cancer* chemotherapeutic *agents.
http://www.tevausa.com/assets/base/products/pi/Cisplatin%20PI%208-2007.pdf
open  pop

CYTO WIPE KIT
CYTO WIPE KIT to measure environmental contamination with the cytostatic drugs cis-platin and carboplatin. Contents This wipe kit contains the materials to take 6 wipe samples from ...
http://www.exposurecontrol.nl/publications/brochure_4.pdf
open  pop

HUMAN TOXIC NEUROPATHY DUE TO
The two most common exceptions are the 2-6 week delay following exposure to organophosphates and the occasional 2 month latency between cis-platin intoxication and neuropathic ...
http://www.neuropathy.org/site/DocServer/Toxin-Induced_Neuropathies.pdf?docID=1603
open  pop

SA022 Abstract PDF (1-up)
Cis platin was more toxic to rat proximal tubule cells (RPT) than to human proximal tubule (HPT) cells, 24 h IC 50 77*4 *M, 121*10 *M respectively.
http://www.biochemistry.org/Portals/0/Conferences/Abstracts/SA022/SA022P005.pdf
open  pop

A promising R
Patients were treated every three weeks for three cycles with either TPF (Taxotere 75 mg/m2 plus cis platin 100 mg/m2 and 5-fluorouracil 1000 mg/m2 a day for four days) or PF ...
http://www.taxotere.com/docs/pdf/C9EF0099-1DA2-4B82-9CCA-BAEA7B7ECEFE.pdf
open  pop

ISMP's List of Confused Drug Names
... CIS platin Car dura* Coumadin* Cat hflo Activase Activase Cedax Cidex ce FAZ olin cef TRIAX one cef TRI AX one ce FAZ olin Cele BREX * Cele XA * Cele BREX * Cerebyx* Cele XA Zy PREXA Cele XA * Cele ...
http://www.ismp.org/Tools/confuseddrugnames.pdf
open  pop

General description
Cis -platin was classified by IARC as a group 2A carcinogen, i.e. sufficient evidence for carcinogenicity in animals but inadequate evidence in humans.
http://www.euro.who.int/document/aiq/6_11platinum.pdf
open  pop

Zangmeister Center Case Study: IGRT for Head and Neck Cancer
... cancer (NPC) occurs in an anatomical site that is poorly accessible to surgeons, and is often advanced at presentation. 1 estandardofcare includes concurrent cis-platin-based ...
http://www.varian.com/media/oncology/treatments/pdf/IGRT_Case_Study_Zangmeister_Swanson.pdf
open  pop

Database
The gallium salts showa their synergistic effect with cis-platin in the treatment of lung cancer and urothelium carcinomas Similarly in ruthenium(III) the active mechanism involves ...
http://dsir.nic.in/reports/tifp/database/metallo.pdf
open  pop

Featured Results: